indicated that the essential antiglobulin components in this type of reaction were anti-fl. In the course of subsequent work further observations were made which provided additional evidence that 'complement-coated' cells were agglutinated by anti-fl1 components of the anti-'non-y' globulins. These observations are contained in the present paper.
SENSMTZED CELLS The antiglobulin sera were tested against red cells, which had been moderately strongly sensitized by an incomplete Rh antibody, against cells sensitized by normal incomplete cold antibody (anti-H), and against cells sensitized by anti-Lea.
Rh antibody never seems to bind complement whereas the normal incomplete cold antibody essentially binds complement. In order to ensure that complement was adsorbed onto the Lewis-sensitized cells, the red cells were first treated with the serum containing antibody (heated to 56°C. for 30 minutes) then washed and exposed to fresh serum. PREPARATION OF 19s GLOBULINS The 'heavy' component was obtained from human plasma by subjecting it to ultra-centrifugation three times after a preliminary separation with ethyl ether.
In accordance with previous observers (MullerEberhard, Kunkel, and Franklin, 1956; Wallenius, Trautman, Kunkel, and Franklin, 1957) Table I . On the basis of their reactions it is possible to divide the reagents broadly into those which react with both types of sensitized cells and those which react with the normal incomplete cold sensitized cells, but not at all or only slightly with Rh-sensitized cells (S.6, S.132, and S.55/84) . No antisera reacted exclusively with Rh-sensitized cells though some (such as S.80) reacted with these cells much more strongly than with normal incomplete cold-sensitized cells.
The reactions with sensitized cells are in some measure reflected in the pattern of precipitation produced by immunoelectrophoresis (Fig. 1 ). It will be observed that those sera which react with both types of sensitized cells have lines in the y region and also an abundance of lines in the a and 9 areas (R.35, Q.C.19/1, P.29, S.70).
S.6 is a notable example of an antiglobulin serum which does not react at all with Rh-sensitized cells. Its precipitation pattern shows no y line and no albumin line. The remaining lines consist of (X1, x2, P19
and a fainter 92 line on the extreme right. This configuration is reproduced by serum 55/84. In this case the antibody which was revealed by the very weak reaction with Rh-sensitized cells was presumably not sufficiently strong to produce a precipitation line in the y area.
Anti-Pi, though similar to S.6 in its reactions with the sensitized cells, differs from it in lacking a f2 line and producing an albumin line. Once again the y line is absent. Important reactions are those displayed by reagents S.132 and S.146 which were produced in a rabbit against human complement. It will be seen that S.132 strongly agglutinates cells sensitized with normal incomplete cold antibody and produces two lines only on immunoelectrophoresis, both of which appear to lie in the ,B region. Despite the weak reactions with Rh-sensitized cells there is no line in the pattern produced by S.132, but in the sample later obtained from the same animal (S.146), a welldeveloped y line appears which agrees with the much stronger agglutination of Rh-sensitized cells; however, the reaction with 'complement-coated' cells remains unchanged.
In general there is a good relationship between the presence or absence of a y line on immunoelectrophoresis and the ability of the reagents to react with Rh-sensitized cells. Furthermore some quantitative correlation is apparent; that is to say, where excess of antibody is indicated by a wellmarked prozone, the y globulin precipitation line is correspondingly strong (S.80, Q. (Fig. 3) . The minimal reduction in activity produced by fraction 10 may be explained by the fact that small amounts of y globulin may display fast mobilities extending as far as the a2 region. It will be seen (Fig. 4) whole serum components was due to a small y globulin component with a comparatively fast mobility. The reactionswith both of the complement-binding antibodies were maximally inhibited by a fraction (fraction 20) which is again identified as pure globulin (Fig. 5) . The zone of inhibition in the reactions with Lewis-sensitized cells was well confined to the fractions containing f,i globulin. The inhibition of reactions with normal incomplete cold-sensitized cells was prolonged into the fl2 region.
ADDITION OF 19s GLOBULINS TO ANTIGLOBULIN SERUM
The addition of an equal volume of 19S protein (Fig. 6) (Fig. 7) . It is unlikely therefore that either anti-a% or anti-fl2M are concerned in the agglutination of 'complement-coated' cells. Matuhasi and Usui (1958) also used a reagent prepared by immunizing a rabbit with adsorbed human complement and it appeared that lines were predominantly in the f1 area on immunoelectrophoresis. (Mollison, 1961, p. 241 ). If such a reaction were contributing to the agglutination in this experiment it is possible that some of the inhibition by faster moving y globulin components was due to the presence of f2M globulin. It is significant therefore that when the antiglobulin serum (R.35) which had been used was tested with Lewis-sensitized cells without the addition of complement a weak agglutination was obtained.
On the other hand, it is shown that in the similar experiment using serum fractions from a case of hypogammaglobulinaemia inhibition of the antiglobulin reactions with 'complement-coated' Lewissensitized cells is confined to only a few fractions containing ,18 globulin. It seems possible therefore that serum G.P. lacks fl2M globulin as well as being deficient in the main y globulin component. This is also suggested by the fact that anti-Pi, which was raised against serum G.P., lacks a f2M line on immunoelectrophoresis (see Fig. 1 ) and furthermore was found not to agglutinate Lewis-sensitized cells unless they were first exposed to complement. Ellis and Gell (1958) reported that the major portion of antibodies to complement was directed against a globulin. Using an anti-complement serum identical to that produced by Professor Gell (S.132 in the present work), Muller-Eberhard and Nilsson (1960) 
